A szolgáltatás eszközei
The European Commission has today proposed to provide Sweden with €4.3 million from the European Globalisation Adjustment Fund (EGF) to help 700 workers made redundant by the pharmaceutical firm AstraZeneca back to employment.
The proposal now goes to the European Parliament and the EU's Council of Ministers for their approval.
Sweden applied for support from the EGF concerning 987 redundancies from AstraZeneca following the closures of the R&D sites in the municipalities of Lund and Umeå and limiting operations in Mölndal and Södertälje.
Of the total 987 redundant workers, 700 with the most difficulties to get new jobs are targeted for support from the EGF. The package aims to help the workers by offering them occupational guidance and job-search assistance, as well as vocational training and retraining, and aid for self-employment.
The total estimated cost of the package is approximately €6.6 million, to which the EGF would provide €4.3 million.